Page last updated: 2024-09-04

satavaptan and Diabetes Mellitus

satavaptan has been researched along with Diabetes Mellitus in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andersen, PK; Jepsen, P; Vilstrup, H; Watson, H1
Bankir, L; Bardoux, P; Bouby, N; Bruneval, P; Heudes, D1

Trials

1 trial(s) available for satavaptan and Diabetes Mellitus

ArticleYear
Diabetes as a risk factor for hepatic encephalopathy in cirrhosis patients.
    Journal of hepatology, 2015, Volume: 63, Issue:5

    Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Follow-Up Studies; France; Hepatic Encephalopathy; Humans; Incidence; Liver Cirrhosis; Male; Middle Aged; Morpholines; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Spiro Compounds; Survival Rate; Time Factors

2015

Other Studies

1 other study(ies) available for satavaptan and Diabetes Mellitus

ArticleYear
Diabetes-induced albuminuria: role of antidiuretic hormone as revealed by chronic V2 receptor antagonism in rats.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2003, Volume: 18, Issue:9

    Topics: Albuminuria; Animals; Antidiuretic Hormone Receptor Antagonists; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Kidney; Male; Morpholines; Rats; Rats, Wistar; Receptors, Vasopressin; Spiro Compounds; Streptozocin; Vasopressins

2003